In-vitro and in-silico studies based discovery of 2-aryl-N-(4-morpholinophenyl)thiazol-4-amines as promising DNA gyrase inhibitors

Mohd. Imran, Abdulaziz Khalaf Alshammari, Khattab Fahed Alfarh, Rakan Khalid Alanazi, Samr Fahed Alfrah, Osama Muqbil Alshammri, Reem Saleh Alanazi, Sumaih Saeed Alsaeed, Feras Salah Albasha, Hanan Furayj Alhulayfi, Syed Mohammed Basheeruddin Asdaq, Abida .

Abstract


Background: DNA gyrase is an important enzyme for the survival of bacteria. Many DNA gyrase inhibitors are in clinical practice. However, these inhibitors also encompass certain toxic and drug/food interactions. This warrants the development of a new template as DNA gyrase inhibitors. Therefore, this study aimed to deliver morpholine-based thiazoles (5a-5l) as safer DNA gyrase inhibitors.

Methods: The 5a-5l were prepared by reacting compound 3 with various aryl thioamides. The structures of 5a-5l were ascertained by their spectral records. The 5a-5l were subjected to their antibacterial activity potential (serial plate dilution method), DNA gyrase inhibiting activity, and toxicity analysis (MTT assay) against HepG2 & Vero cell lines. The in-silico studies (pharmacokinetic parameters and molecular docking) of 5a-5l were likewise performed.

Results: It was surprisingly observed that the MIC values of 5a-5l were equal to the MIC values of ciprofloxacin (12.5 µg/ml) against the tested bacteria, whereas the DNA gyrase inhibitory activity (IC50 in µg/ml) of 5h (3.52), 5g (3.76), 5f (3.88), 5e (4.08), 5l (4.11), 5b (4.28), 5k (4.28), 5i (4.30), and 5d (4.32) was equal/better than ciprofloxacin (4.32). The MTT assay also implied the non-cytotoxic nature of 5a-5l against HepG2 & Vero cell lines up to 200 µg/ml concentration. The docking outcomes indicated a similar binding pattern of 5a-5l and ciprofloxacin at the active site of DNA gyrase, wherein 5a-5l displayed a better binding affinity for the active site. The in-silico toxicity data employing the ProTox-II web server indicated no hepatotoxicity, carcinogenicity, immunotoxicity, mutagenicity, or cytotoxic effect of 5a-5l. Also, the SwissADME software supported the drug-likeliness properties and high gastrointestinal absorption of 5a-5l.

Conclusion: Compounds 5h, 5g, 5f, 5e, 5l, 5b, 5k, 5i, and 5d are potent DNA gyrase inhibitors with promising safety profiles.

Keywords: Discovery; Morpholine; Thiazole; DNA gyrase; MTT assay; Docking


Full Text:

PDF

References


Fisher LM, Pan XS. Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities. Methods in Molecular Medicine, (2008); 142: 11-23.

Eyler RF, Shvets K. Clinical pharmacology of antibiotics. Clinical Journal of the American Society of Nephrology, (2019); 14(7): 1080-1090.

Panneerselvam P, Nair RR, Vijayalakshmi G, Subramanian EH, Sridhar SK. Synthesis of Schiff bases of 4-(4-aminophenyl)-morpholine as potential antimicrobial agents. European Journal of Medicinal Chemistry, (2005); 40(2): 225-229.

Janakiramudu DB, Rao DS, Srikanth C, Madhusudhana S, Murthy PS, et al. Sulfonamides and carbamates of 3-fluoro-4-morpholinoaniline (linezolid intermediate): synthesis, antimicrobial activity and molecular docking study. Research on Chemical Intermediates, (2018); 44(1): 469-489.

Narsimha S, Nukala SK, Jyostna TS, Ravinder M, Rao MS, et al. One-pot synthesis and biological evaluation of novel 4-[3-fluoro-4-(morpholin-4-yl)]phenyl-1 H-1,2,3-triazole derivatives as potent antibacterial and anticancer agents. Journal of Heterocyclic Chemistry, (2020); 57: 1655– 1665.

Nagaraj A, Ravi G, Kumar SS, Raghaveer S, Rana N. Synthesis and antimicrobial evaluation of novel 1,3-thiazolan-4-one derivatives. Research & Reviews: Journal of Chemistry, (2014); 3(2): 17-21.

Gul S, Aziz-ur-Rehman, Abbasi MA, Khan KM, Nafeesa K, et al. Synthesis, antimicrobial evaluation and hemolytic activity of 2-[[5-alkyl/aralkyl substituted-1,3,4-oxadiazol-2-yl]thio]-N-[4-(4-morpholinyl)phenyl]acetamide derivatives. Journal of Saudi Chemical Society, (2017); 21(1): 425-433.

Kashyap A, Adhikari N, Das A, Shakya A, Ghosh SK, et al. Review on synthetic chemistry and antibacterial importance of thiazole derivatives. Current Drug Discovery Technologies, 2018; 15(3): 214-228.

Rai SK, Patil RI, Roy SS, Sharma K, Dwivedi R, et al. Novel apoptosis signal-regulating kinase 1 inhibitors. PCT International Patent Application Publication Number WO2020261294A1, 2020. Available at https://patents.google.com/patent/WO2020261294A1/en?oq=WO2020261294A1.

Ansari MI, Khan SA. Synthesis and antimicrobial activity of some novel quinoline-pyrazoline-based coumarinyl thiazole derivatives Medicinal Chemistry Research, (2017); 26: 1481-1496.

Mohi El-Deen EM, Abd El-Meguid EA, Karam EA, Nossier ES, Ahmed MF. Synthesis and biological evaluation of new pyridothienopyrimidine derivatives as antibacterial agents and Escherichia coli Topoisomerase II inhibitors. Antibiotics (Basel), (2020); 9(10): 695.

Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for cell viability assays. Food Frontiers, (2020); 1: 332–349.

Ammerman NC, Beier-Sexton M, Azad AF. Current Protocols in Microbiology, (2008); Appendix 4: Appendix 4E.

Imran M, Mohd AA, Nayeem N, Alaqel SI. In silico studies-assisted design, synthesis, and discovery of biologically active isatin derivatives. Tropical Journal of Pharmaceutical Research, (2023); 22(6): 1263-1269.

Eswaramoorthy R, Hailekiros H, Kedir F, Endale M. In silico Molecular Docking, DFT Analysis and ADMET Studies of Carbazole Alkaloid and Coumarins from Roots of Clausena anisata: A Potent Inhibitor for Quorum Sensing. Advances and Applications in Bioinformatics and Chemistry, (2021); 14: 13-24.

Mohd AA, Imran M, Alnaser NY, Altimyat SS, Al-Otaibi NM, et al. Discovery of new isoniazid derivatives as anti-tubercular agents: In silico studies, synthesis, and in vitro activity evaluation. Oriental Journal of Chemistry, (2023); 39(6): 1510-1520.

Imran M, Mohd AA, Nayeem N, Al-Otaibi NM, Homoud M, et al. Synthesis and cyclooxygenase-2 inhibitory activity evaluation of some pyridazine derivatives. Oriental Journal of Chemistry, (2023); 39(5): 1113-1119.

Imran M. 2-Butyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one: Synthesis, In Silico Studies and In Vitro Cyclooxygenase-2 Inhibitory Activity. Molbank, (2020); 2020(3): M1155.

Khan A, Diwan A, Thabet HK, Imran M, Bakht MA. Discovery of novel pyridazine-based cyclooxygenase-2 inhibitors with a promising gastric safety profile. Molecules, (2020); 25(9): 2002.

Walden DM, Khotimchenko M, Hou H, Chakravarty K, Varshney J. Effects of magnesium, calcium, and aluminum chelation on fluoroquinolone absorption rate and bioavailability: A computational study. Pharmaceutics, (2021); 13(5): 594.

Kozieł R, Zabłocki K, Duszyński J. Calcium signals are affected by ciprofloxacin as a consequence of reduction of mitochondrial DNA content in Jurkat cells. Antimicrobial Agents and Chemotherapy, (2006); 50(5): 1664-1671.

Pham TDM, Ziora ZM, Blaskovich MAT. Quinolone antibiotics. MedChemComm, (2019); 10(10): 1719-1739.




DOI: http://dx.doi.org/10.62940/als.v11i4.3514

Refbacks

  • There are currently no refbacks.